Skip to main content

Artemis Funds (Lux) – SmartGARP Global Emerging Markets Equity update

The manager reports on the fund over the quarter to 30 June 2024 and the outlook.

Source for all information: Artemis as at 30 June 2024, unless otherwise stated. The fund is actively managed. The fund's objective is to increase the value of shareholders’ investments primarily through capital growth. 

  • Emerging market stocks remain cheap and unloved, with abundant growth and income opportunities.
  • Value bias in the fund remains substantial, 37% discount to MSCI EM…
  • …with favourable quality and growth characteristics compared to the market.
     

Artemis SmartGARP Global Emerging Markets Equity Fund - Key financial metrics

  12m forward P/E ROE Dividend yield
Fund 7.7x 14.9% 5.1%
Benchmark 12.3x 14.4% 2.9%
Relative -37% 0.6% 78%
Source: Artemis, Bloomberg, MSCI as at 30 June 2024. ROE is a blend of 3-year trailing and 2-year forward

Performance – upturn in emerging markets on improving sentiment

Optimism around easing of monetary policy and encouraging economic data from around the world were supportive tailwinds for stocks. With diminishing signs of recessionary concerns, particularly in the US, risk appetite seems to have picked up. Economic data continues to improve, against a backdrop of benign inflation. Technology and cyclical areas of the market led, as traditional defensives such as healthcare and consumer staples lagged. Shareholder reforms in Korea and China aimed to emulate Japan’s success at improving capital management and companies manufacturing component parts for AI surged. Improved sentiment is supportive to EM, given the pessimism reflected in investor positioning.

Attribution – favourable tailwinds for our holdings

A diverse group of companies contributed to performance in the quarter, reflecting several positive tailwinds developing across our holdings. Top contributors in the second quarter were Amara Raja (batteries), Cosco Shipping (transportation), Indus Towers (telecoms), CNOOC (energy) and Coca Cola Icecek (beverages). AI themed stocks in Taiwan also performed well – our holdings in Wiwynn and Hon Hai featured amongst top contributors. On the negative side, weaker sentiment towards Brazil was a drag. Softer commodity prices created headwinds to our positions in the sector, with Lao Feng Xiang and Usiminas amongst detractors. Despite the setbacks, the fund delivered strong outperformance in the quarter.

Activity – continue to rotate towards cyclicals, adding to industrials

As manufacturing data continues to signal a broad recovery in Asia, the corporate newsflow for more cyclical areas of the market has also been improving. Asia has beneficiaries amongst commodities and supply chain winners to the AI theme. We selectively rotated towards the opportunities during the quarter, funding them with sales where fundamental prospects have diminished.

Additions

China recovery – Tencent, Jiangxi Copper, Shenzhen New Energy (renewables), Cosco Shipping
Pharmaceuticals – Richter (Hungary, drug producer)

Reductions

China rotation – Alibaba, PICC, Netease and Lao Feng Xiang

The result of these changes is that the fund continues to offer an attractive combination of extremely low valuations and attractive growth prospects. We remain overweight China, Brazil and Korea and underweight India, Taiwan and Saudi Arabia. At the sector level, financials, consumer discretionary and industrials feature as the largest overweights. Materials, technology and consumer staples the largest underweights.

We remain positioned for a rotation into value stocks

The fund continues to offer an attractive combination of extremely low valuations and attractive growth prospects. The fund is trading around book value, and it offers a forward P/E of 7.7 vs 12.3 for the index (37% discount). To put this valuation into context, the fund trades on half the valuation of developed markets (2x book value) and a third of US stocks (3x book value).

We think our discipline around valuations is likely to be a rewarding strategy as we progress through 2024 and for the years ahead. Typically, significant exposure to value stocks coincides with distressed balance sheets and volatile earnings. This doesn’t appear to be the case today, the fund offers favourable quality and growth characteristics. For instance, our net debt/EBITDA is low, and our free cash flow yield is much higher than the market. We can achieve these compelling financial characteristics because of some behavioural biases that have caused over valuations in some parts of the market, leaving others under appreciated.

EM – Pessimism well reflected in prices; cyclical upturn presents opportunity

There are many reasons for poor sentiment towards EM today. The Chinese economic recovery has so far been underwhelming. Geopolitics creates uncertainty: election results in India, Mexico and South Africa could signal policy changes and the US election looms.

On the positive side, potential for stimulus measures and reasonable levels of interest rates offer support. Chinese stocks have struggled for over a decade and their share prices are well reflective of the risks highlighted. Positive catalysts such as reforms and growth initiatives have the potential to surprise investors. More broadly, EM stocks are trading on multi-decade valuation lows against developed markets across a range of metrics.

When times are bad, risk aversion can lead to indiscriminate selling. We believe this creates opportunities for disciplined investors and our process has been designed to look for the companies where the fundamentals are signalling good news, yet share prices are not reflecting this optimism.

Our focus on fundamentals continues

We continue to believe that a focus on companies’ fundamentals, such as earnings and cash flow growth, combined with a strict discipline around valuations, offers the best way to navigate markets in the months ahead. Despite the last three years being very disappointing for passive EM investors, there has been no shortage of companies performing well. The compelling financial characteristics of our fund give us confidence that regardless of the direction markets take, we can continue to deliver good outcomes.

Fund 10-year discrete performance

Discrete performance, 12 months to 30 June
2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Artemis Funds (Lux) – SmartGARP Global Emerging Markets Equity 12.4% 12.1% -19.0% 44.3% -12.6%  - - - - -
MSCI EM (Emerging Markets) NR USD 7.5% 1.7% -25.3% 40.9% -3.4% - - - - -
Past performance is not a guide to the future.
Source: Lipper Limited/Artemis to 30 June 2024 for class I Acc USD
All figures show total returns with dividends and/or income reinvested, net of all charges.
Performance does not take account of any costs incurred when investors buy or sell the fund.
Returns may vary as a result of currency fluctuations if the investor's currency is different to that of the class.
Benchmark: MSCI Emerging Markets Index; the benchmark is a point of reference against which the performance of the fund may be measured. Management of the fund is not restricted by this benchmark. The deviation from the benchmark may be significant and the portfolio of the fund may at times bear little or no resemblance to its benchmark.

Investment in a fund concerns the acquisition of units/shares in the fund and not in the underlying assets of the fund.

Reference to specific shares or companies should not be taken as advice or a recommendation to invest in them.

For information on sustainability-related aspects of a fund, visit the relevant fund page on this website.

For information about Artemis’ fund structures and registration status, visit artemisfunds.com/fund-structures

Any research and analysis in this communication has been obtained by Artemis for its own use. Although this communication is based on sources of information that Artemis believes to be reliable, no guarantee is given as to its accuracy or completeness.

Any statements are based on Artemis’ current opinions and are subject to change without notice. They are not intended to provide investment advice and should not be construed as a recommendation.

Third parties (including FTSE and Morningstar) whose data may be included in this document do not accept any liability for errors or omissions. For information, visit artemisfunds.com/third-party-data.

Important information
The intention of Artemis’ ‘investment insights’ articles is to present objective news, information, data and guidance on finance topics drawn from a diverse collection of sources. Content is not intended to provide tax, legal, insurance or investment advice and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security or investment by Artemis or any third-party. Potential investors should consider the need for independent financial advice. Any research or analysis has been procured by Artemis for its own use and may be acted on in that connection. The contents of articles are based on sources of information believed to be reliable; however, save to the extent required by applicable law or regulations, no guarantee, warranty or representation is given as to its accuracy or completeness. Any forward-looking statements are based on Artemis’ current opinions, expectations and projections. Articles are provided to you only incidentally, and any opinions expressed are subject to change without notice. The source for all data is Artemis, unless stated otherwise. The value of an investment, and any income from it, can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested.